BIO: FDA Hopes To Send PDUFA Goals To Congress Before End Of 2016

A head biotechnology industry lobbyist says FDA hopes to send the final prescription drug user fee goals letter to Congress before the end of the year to avoid the “hiatus pit” that occurs during the changes of administration. Kay Holcombe, senior vice president for science policy at the Biotechnology Innovation Organization, told reporters Wednesday (July 20) that this is the first time the prescription drug user fee law is being reauthorized during a presidential election year. “A lot of the...